✦ LIBER ✦

Prospects and challenges for the development of new therapies for Ewing sarcoma

✍ Scribed by Grohar, Patrick J.; Helman, Lee J.

Book ID: 117999869
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 631 KB
Volume: 137
Category: Article
ISSN: 0163-7258
DOI: 10.1016/j.pharmthera.2012.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New therapies for Duchenne muscular dyst

New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials

✍ Giulio Cossu; Maurilio Sampaolesi 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 322 KB

Opportunities and challenges for the dev

Opportunities and challenges for the development of pharmacological therapies for obesity treatment

✍ M. A. Cawthorne 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Prospects and challenges of developing n

Prospects and challenges of developing new agents for tough Gram-negatives

✍ Annette L Meyer 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Reawakening fetal hemoglobin: prospects

Reawakening fetal hemoglobin: prospects for new therapies for the -globin disorders

✍ Bauer, D. E.; Kamran, S. C.; Orkin, S. H. 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 330 KB

Challenges and successes in developing n

Challenges and successes in developing new therapies for hepatitis C

✍ De Francesco, Raffaele; Migliaccio, Giovanni 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 406 KB

Regulation of apoptosis and proliferatio

Regulation of apoptosis and proliferation in Ewing's sarcoma—opportunities for targeted therapy

✍ Udo Kontny 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

The Ewing's sarcoma family of tumors are malignant tumors of bone and soft tissue which occur predominantely in children and adolescents. Whereas cure rates for patients with localized tumors are around 70%, survival rates for patients with metastases or relapse are poor in spite of intensive chemo-